- Home
- UG vs PASG Comparison
UG vs PASG Comparison
Compare UG & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UG
- PASG
- Stock Information
- Founded
- UG 1942
- PASG 2017
- Country
- UG United States
- PASG United States
- Employees
- UG N/A
- PASG N/A
- Industry
- UG Package Goods/Cosmetics
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- UG Consumer Discretionary
- PASG Health Care
- Exchange
- UG Nasdaq
- PASG Nasdaq
- Market Cap
- UG 45.5M
- PASG 42.2M
- IPO Year
- UG N/A
- PASG 2020
- Fundamental
- Price
- UG $9.74
- PASG $0.64
- Analyst Decision
- UG
- PASG Strong Buy
- Analyst Count
- UG 0
- PASG 3
- Target Price
- UG N/A
- PASG $8.00
- AVG Volume (30 Days)
- UG 12.1K
- PASG 1.2M
- Earning Date
- UG 11-08-2024
- PASG 11-13-2024
- Dividend Yield
- UG 6.06%
- PASG N/A
- EPS Growth
- UG 38.11
- PASG N/A
- EPS
- UG 0.76
- PASG N/A
- Revenue
- UG $12,312,275.00
- PASG N/A
- Revenue This Year
- UG N/A
- PASG N/A
- Revenue Next Year
- UG N/A
- PASG N/A
- P/E Ratio
- UG $13.01
- PASG N/A
- Revenue Growth
- UG 11.51
- PASG N/A
- 52 Week Low
- UG $6.75
- PASG $0.45
- 52 Week High
- UG $16.25
- PASG $1.79
- Technical
- Relative Strength Index (RSI)
- UG 42.35
- PASG 48.32
- Support Level
- UG $9.70
- PASG $0.65
- Resistance Level
- UG $9.95
- PASG $0.90
- Average True Range (ATR)
- UG 0.27
- PASG 0.13
- MACD
- UG 0.14
- PASG -0.02
- Stochastic Oscillator
- UG 58.18
- PASG 5.73
About UG United-Guardian Inc.
United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.